we determined actin remodeling as a crucial PTEN regulated process

recent reports have called into question whether Akt is actually a expected effector of PI3K route influenced oncogenesis. Furthermore, emerging data suggest that Akt inhibitors may be of limited clinical application Erlotinib in cancers driven by mutations in PTEN. Hence, the degree to which Akt is a necessary effector of PTEN growth reduction is not clear at this time. How may possibly abrogation of cell size gate control actually drive neoplasia? We hypothesize that the explanation might be associated with the eukaryotic cell gate that stops cell division in the level of the cell cycle until cells have reached adequate size to split up their biomass into two daughter cells. Cells may be permitted by this checkpoint to enter the cell cycle, causing enhanced proliferation and neoplasia, although in normal-sized cells, this checkpoint is vigilant in avoiding cell division and proliferation, in oversized PTENdeficient Infectious causes of cancer cells. This speculation, however, remains experimentally untested. As well as showing that Akt is dispensable for cell size checkpoint control, we revealed actin remodeling as a crucial PTEN regulated process that is associated with regulating cell size control. These results are in line with the early work of Goberdhan et al., who demonstrated that in D. melanogaster, PTEN influences cytoskeletal organization in numerous cell types. Here we have identified a physical interaction between PTEN and an actin remodeling complex which includes actin, actin, and several actin remodeling proteins, including EPLIN and gelsolin. This finding raises yet another unsure question: which of those proteins interacts directly with PTEN? We imagine that PTEN interacts directly with actin and indirectly with the remodeling proteins, since actin seems to be the most abundant protein in PTEN immunoprecipitates. Furthermore, PTEN contains a domain with homology to tensin, an identified actin interacting Vortioxetine protein. A definitive answer to this question will need the ability to recapitulate the interactions with purified components, and these efforts are ongoing within our laboratory. This newly recognized connection between PTEN and the actin remodeling complex is reminiscent of the current work of van Diepen et al., who demonstrated that PTEN interacts with myosin V in neurons. These researchers further showed that this interaction is important for the ability of PTEN to control the size of these neurons. While we didn't specifically identify myosin V as a PTEN interacting protein in our study, we speculate this omission arrives to cell-type specific differences in the expression pattern of the myosin V gene. Determination of whether myosin V is a part of a larger actin containing complex in the neurons utilized in this study will be interesting.